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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYAlthough SOX2+ stem cells are present in the postnatal pituitary gland, how they are regulatedmolecularly andwhether they are required
for pituitary functions remain unresolved questions. Using a conditional knockout animal model, here we demonstrate that ablation of
the canonical Notch signaling in the embryonic pituitary gland leads to progressive depletion of the SOX2+ stem cells and hypoplastic
gland. Furthermore, we show that the SOX2+ stem cells initially play a significant role in contributing to postnatal pituitary gland expan-
sion by self-renewal and differentiating into distinct lineages in the immediate postnatal period. However, we found that within several
weeks postpartum, the SOX2+ stem cells switch to an essentially dormant state and are no longer required for homeostasis/tissue adap-
tation. Our results present a dynamic tissue homeostatic model in which stem cells provide an initial contribution to the growth of the
neonatal pituitary gland, whereas the mature gland can be maintained in a stem cell-independent fashion.INTRODUCTION
The pituitary gland plays a fundamental role in regulating a
wide variety of physiological functions, including growth,
lactation, stress response, reproduction, and metabolism.
These complex functions are regulated by six distinct hor-
mone-producing cell types distinguished by the different
hormones they synthesize and secrete, including cortico-
tropes secreting adrenocorticotrophic hormone (ACTH),
thyrotropes secreting thyroid-stimulating hormone
(TSH), somatotropes secreting growth hormone (GH), lac-
totropes secreting prolactin (PRL), gonadotropes secreting
luteinizing hormone (LH) and follicle-stimulating hor-
mone (FSH), andmelanotropes secreting melanocyte-stim-
ulating hormone (MSH). During pituitary organogenesis,
these lineages emerge in a stereotypical spatio-temporal
pattern from a common ectodermal primordium, Rathke’s
pouch (RP). Extensive studies in model systems have
demonstrated that multiple signaling pathways, transcrip-
tion factors, and cofactors define the genetic hierarchy that
controls embryonic pituitary development (Davis et al.,
2011; Kelberman et al., 2009; Zhu et al., 2007).
We andothers have shownpreviously that the evolution-
arily conserved Notch signaling pathway plays an impor-
tant role in early embryonic pituitary development (Kita
et al., 2007; Raetzman et al., 2004, 2007; Zhu et al., 2006).
Delta/Notch signaling, mediated by the critical transcrip-
tion factor RBP-J, acts to prevent progenitor cells in the RP
from premature differentiation through Hes1, one of the
downstream target genes of theNotch pathway. It also con-
trols the competence of progenitor cells by maintaining1196 Stem Cell Reports j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 Thexpressionof theProp1gene,whichencodes apituitary-spe-
cific, paired-like homeodomain transcription factor neces-
sary for the commitment of the PIT1 lineage of three cell
types—somatotropes, thyrotropes, and lactotropes. In the
absence of canonical Notch signaling, resulting from dele-
tionof theRbp-J gene at embryonic day (E) 10.5 in theRPus-
ing Pitx1-Cre transgenic mice, the progenitors adopt an
early-born corticotrope cell fate at the expense of the late-
arising PIT1 lineage (Kita et al., 2007; Raetzman et al.,
2007; Zhu et al., 2006). Interestingly, the proliferating pro-
genitors, residing in the periluminal region, are still present
at the end of embryonic development in the mutant pitui-
tary gland (Zhu et al., 2006). However, the mutant animals
died of cleft palate shortly after birth because of broad
expression of Pitx1-Cre in the oral ectoderm (unpublished
data), leaving an open question regarding whether
continuedNotch signaling is required tomaintain these pi-
tuitary progenitors in the postnatal period. Recently, it has
been suggested that Notch signaling is required for progen-
itor maintenance based on deletion of the Notch2 gene
in the embryonic RP. However, despite a progressive
decrease in the number of pituitary progenitors, these cells
remain in the postnatal gland in this animal model, partic-
ularly in the anterior lobe (Nantie et al., 2014). An animal
model with specific and complete depletion of Notch
signaling is required to provide an unambiguous answer.
At birth, all of the endocrine cell lineages are present in
the mouse pituitary gland, but the gland continues to
grow and mature substantially after birth, particularly dur-
ing the first few postnatal weeks. It has been documented
that this postnatal pituitary gland expansion in the rat ise Authors
only partially brought about via proliferation of preexisting
differentiated hormone-producing cells (Carbajo-Pe´rez and
Watanabe, 1990; Taniguchi et al., 2000, 2001a, 2001b,
2002). Double immunolabeling of hormone and prolifera-
tionmarkers reveals that 10%–30%of the proliferating cells
are differentiated endocrine cells, implying that someof the
postnatal proliferationmight take place in undifferentiated
cells. On the other hand, the mature pituitary gland has a
low turnover rate under basal conditions (Florio, 2011).
However, one important feature of the pituitary gland is
its plasticity. The cellular composition of the mature gland
can change flexibly to adapt to the physiological or patho-
logical demands of the organism (Levy, 2002). Recently,
postnatal pituitary stem cells have been identified based
on expression of a variety of stem cell-specific markers,
including SOX2, SOX9, E-Cadherin, NES, and the pitui-
tary-specific transcription factor LHX3 (Chen et al., 2009;
Fauquier et al., 2008; Garcia-Lavandeira et al., 2009; Glei-
berman et al., 2008; Rizzoti, 2010; Vankelecom and Chen,
2014). These cells are localized in the marginal region be-
tween the intermediate lobe and the anterior lobe, and,
when cultured in vitro, they are capable of self-renewal
and differentiation into diverse hormone-producing pitui-
tary cell types, implying their ‘‘stemness.’’ In vivo character-
izations of these SOX2+ cells have shown that they aremost
abundant in the neonatal pituitary gland (Gremeaux et al.,
2012). Recent studies of cell ablation of terminally differen-
tiated cells have suggested that these SOX2+ cells may
contribute to pituitary regeneration (Fu et al., 2012; Fu
and Vankelecom, 2012). In addition, lineage tracing of
SOX2+, SOX9+ cells have provided genetic evidence that
these cells can contribute to organ homeostasis and tissue
adaptation (Andoniadou et al., 2013; Rizzoti et al., 2013).
Expression of the Notch signaling component in postnatal
stem cells has been described previously (Chen et al., 2006,
2009; Nantie et al., 2014; Tando et al., 2013; Vankelecom
and Gremeaux, 2010). Interfering with Notch activation
affects stem cell number in pituitary primary culture, impli-
cating a critical role of Notch signaling in stem cell prolifer-
ation (Chen et al., 2006; Nantie et al., 2014; Tando et al.,
2013). However, whether Notch signaling is essential for
pituitary stem cell proliferation in vivo and whether these
cells are necessary for any normal physiological pituitary
functions remains unknown.
Herewedemonstrate that postnatal pituitary SOX2+ stem
cells are derived from the embryonic RP and that the Notch
signaling pathway is essential for their proliferation, main-
tenance, and postnatal pituitary expansion. Furthermore,
we present evidence that SOX2+ stem cells make a signifi-
cant contribution to neonatal pituitary expansion but
that they gradually switch to an essentially quiescent state
so that they are no longer required for homeostasis and tis-
sue plasticity in the mature gland. Our results suggest thatStem Cell Repcommitted cells are capable of adapting to physiological de-
mands and contribute to pituitary gland plasticity.RESULTS
Notch Signaling Is Active in Pituitary Postnatal Stem
Cells
Components of the Notch signaling pathway exhibit dy-
namic expression patterns during pituitary organogenesis.
Their expression is high in the RP but becomes attenuated
at E13.5 in the perspective anterior lobe as cells begin to un-
dergo lineage commitment (Raetzman et al., 2004; Zhu
et al., 2006). However, we observed that the expression of
Notch2, Dll1, Dll3, and the downstream target gene Hes1
persists in the periluminal region at E17.5, where the pro-
spective postnatal pituitary stem cells reside (Figure 1A; Fig-
ures S1A–S1D). To further elucidate the status of Notch
signaling inpostnatal stemcells, weperformed immunoflu-
orescence staining using a specific anti-Hes1 antibody (Fig-
ure 1B). All periluminal cells express SOX2 and E-Cadherin,
and most of them express Hes1, suggesting that Notch
signaling remains active in these cells. Double immunolab-
eling revealed that some of the SOX2+ stem cells co-ex-
pressed SOX9, LHX3, NES, and PROP1 (Figures 1C–1F;
Figures S1E–S1H). Interestingly, SOX9 appears to be more
highly expressed in the periluminal layer next to the inter-
mediate lobe,whereas LHX3andPROP1aremore expressed
toward the anterior lobe. These results, collectively, imply
heterogeneity within the stem cell population.Generation of the Prop1-Cre Transgenic Mice
To circumvent the neonatal lethality and early develop-
mental defects in the Rbp-Jf/f, Pitx1-Cre mice as described
before (Zhu et al., 2006), we generated a Cre line using the
genetic information of the Prop1 gene to drive expression
exclusively in the RP during pituitary organogenesis. We
learned that the first intron of the Prop1 gene is essential
for its expression based on the following observations. First,
in the previously generated Prop1 knockout mice, where
exons 2 and 3 and all introns were replaced with in-frame
fusion of the LacZ cassette, LacZ failed to be expressed
(Olson et al., 2006). Second, the first intron of the Prop1
gene is evolutionally conserved and is required tomaintain
Prop1 gene expression in response to early Notch signaling
(Zhu et al., 2006). Consistent with these findings, it was
shown later that the first intron of the Prop1 gene can func-
tion as a pituitary-specific enhancer when placed together
withaheterogeneouspromoter (Wardet al., 2007).Wemap-
ped the critical region to a 2.2-kbpromoter/enhancer region
of theProp1 gene, comprisedof approximately 0.7 kbof pro-
moter sequence, the first exon, and the first intron region
(unpublished data). We subsequently generated Prop1-Creorts j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 The Authors 1197
Figure 1. Characterizations of Pituitary
Stem Cells and Prop1-Cre Transgenic Mice
(A) In situ hybridization of the Notch target
gene Hes1 at E17.5 revealed that it is highly
expressed in the periluminal region.
(B–F) Immunofluorescence staining of Hes1
(B), SOX2/E-Cadherin (C), SOX2/LHX3 (D),
SOX2/SOX9 (E), and SOX2/NES (F) in a
2-month-old pituitary gland. Arrows indi-
cate representative double-positive cells.
(G) The Prop1-Cre transgenic line is driven
by the 2.2-kb promoter/enhancer region of
the Prop1 gene. Blue boxes, exons 1 and 2;
int1, intron 1.
(H–J) LacZ reporter analysis of Prop1-Cre,
Rosa-LacZ embryos in whole-mount (H) and
middle sagittal frozen sections at E12.5 (I)
and E14.5 (J). LacZ activity at E14.5 is de-
tected in all cells in the anterior and in-
termediate lobes of the embryonic pituitary
gland. It is noted that ectopic Cre activity is
detected in the olfactory epithelium (H).
(K) Immunofluorescence staining of LHX3
at E14.5.
(L and M) Dual immunofluorescence stain-
ing of GFP/PIT1 and GFP/SOX2 in a Prop1-
Cre, Z/EG postnatal day 22 pituitary gland.
AL, anterior lobe; IL, intermediate lobe; PL,
posterior lobe. Scale bars, 200 mm (A);
50 mm (B–F, L, and M), 500 mm (H), 100 mm
(I–K).transgenic mice using the same genomic information (Fig-
ure 1G). This Cre line expresses CRE in many cells in the
RP at E12.5, similar to endogenous PROP1 expression (Fig-
ures S1I–S1J) and, consistently, when crossed with Rosa26-
LacZ reporter mice, can mediate LoxP recombination in
manyRPprogenitors at E12.5, as evidencedbyLacZ staining
on whole mounts and sections (Figures 1H and 1I) and in1198 Stem Cell Reports j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 Thalmost all cells in the anterior and intermediate lobes of
thepituitaryglandatE14.5andpostnatalday(P)0 (Figure1J;
Figure S1K). The LacZ activity at E14.5 is almost identical to
the expression pattern of LHX3 (Figure 1K), a critical tran-
scription factor required for early pituitary development
and expressed in every embryonic endocrine cell type and
their precursors. Therefore, theProp1-Cre line caneffectivelye Authors
Figure 2. Proliferating SOX2+ Progenitor Cells in the Embryonic Pituitary Gland Are Reduced in Rbp-Jf/f, Prop1-Cre Mutants
(A–H) Double immunofluorescence labeling of SOX2 and KI67 of wild-type controls (A, C, E, and G) and Rbp-Jf/f, Prop1-Cremutants (B, D, F,
and H) at E14.5 (A–D) and E17.5 (E–H) showed reduced numbers of SOX2+ KI67+ cells in the Rbp-Jf/f, Prop1-Cre mutants, initially in the
anterior lobe at E14.5 and later in the intermediate lobe at E17.5. Arrows indicate representative double-positive cells.
(I–L) Double immunofluorescence labeling of POMC and KI67 at E17.5 revealed that periluminal KI67+ cells in the intermediate lobe
(I and K) are absent in the Rbp-Jf/f, Prop1-Cre mutants (J and L).
(M and N) Double immunofluorescence labeling of PIT1 and TSHb at E17.5. The anterior lobe in the mutant (N) is smaller than in the wild-
type control (M), with reduced numbers of PIT1+ and TSHb+ cells.
(O and P) Immunofluorescence labeling of GH in the wild-type control (O) and Rbp-Jf/f, Prop1-Cre mutants (P) at E17.5.
The dashed lines indicate the lumen between the intermediate and anterior lobes. The dashed areas in (A), (B), (E), (F), (I), and (J) are
also presented in (C), (D), (G), (H), (K), and (L), respectively. Scale bars, 100 mm (A, B, E, F, I, J, and M–P) and 50 mm (C, D, G, H, K, and L).mediate recombination in theRPand label almost all cells in
the anterior and intermediate lobes of the pituitary gland.
Moreover, to probe the origin of pituitary postnatal SOX2+
cells, we crossed Prop1-Cre with Z/EG reporter mice, with
double immunofluorescence labeling in the postnatal pitu-
itarygland fromProp1-Cre,Z/EGmice, revealing thatEGFP is
co-labeledwith SOX2+ as well as PIT1+ cells, suggesting that
postnatal SOX2+ stem cells are derived from the embryonic
RP progenitors (Figures 1L and 1M).
Notch Signaling Is Required to Maintain Pituitary
Stem Cells
To explore the potential functions of Notch signaling in
late pituitary organogenesis and postnatal stem cells, we
generated Rbp-Jf/f, Prop1-Cre mice. At E12.5 in pituitaryStem Cell Repdevelopment, all RP progenitor cells express SOX2, and
most of the luminal SOX2+ cells are proliferating, as re-
vealed by double-labeling of SOX2 and KI67 (Figure S1L).
By E14.5, expression of SOX2 is confined to the intermedi-
ate lobe and periluminal cells in the anterior lobe (Figures
2A and 2C). In the mutant embryos, the number of prolif-
erating SOX2+KI67+ progenitor cells was decreased at E14.5
(Figures 2B and 2D). By E17.5, there were no KI67+ cells
detectable in the intermediate lobe, and they were
decreased markedly in the periluminal region of the ante-
rior lobe (Figures 2E–2H). Expression of LHX3 at E17.5 is
similar to that of SOX2, high in the intermediate lobe
and periluminal cells of the anterior lobe. Consistently, in
the mutant embryos, there was a reduction in the number
of LHX3+ KI67+ cells in the periluminal region (Figuresorts j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 The Authors 1199
S2A–S2D). No increased apoptosis was observed in the mu-
tants by either terminal deoxynucleotidyl transferase dUTP
nick-end labeling (TUNEL) assay or immunofluorescence
labeling with activated caspase-3 (Figures S2E–S2H). In
addition, the intermediate lobe at E17.5 in the mutant
was populated with POMC+ melanotropes, consistent
with the idea that SOX2+ KI67+ cells may differentiate pre-
maturely into melanotropes (Figures 2I–2L). On the other
hand, the ontogeny of PIT1+ lineages in the anterior lobe,
which is mutually exclusive with SOX2+ cells (Figures
S2I–S2L), occurred at the appropriate times. There was,
however, a decrease in the number of PIT1+ cells, including
GH+ somatotropes and TSHb+ thyrotropes (Figures 2M–2P;
Figures S2M and S2N), perhaps because of progressive
depletion of the SOX2+ KI67+ progenitors.
The SOX2+ cells were examined further in postnatal pitu-
itary glands (Figure 3). At P0, SOX2+ E-Cadherin+ stem cells
were present in the periluminal region and as small clusters
in the anterior lobe in thewild-type pituitaries. By contrast,
in themutant gland, these SOX2+ cells were largely absent,
except for a few remaining cells with reduced levels of
SOX2 and E-Cadherin (Figures 3A and 3B). Expression of
PROP1, which was present in some SOX2+ stem cells in
the wild-type control, was largely undetectable in the
mutant gland (Figures 3C and 3D). By P10, the periluminal
pituitary stem cells as well as stem cell clusters in the ante-
rior lobe, characterized by SOX2, SOX9, and E-Cadherin la-
beling, were almost completely absent in the mutant
glands (Figures 3E–3H). Consistent with these observa-
tions, RNA levels of the Sox2, E-Cadherin, and Prop1 genes
as well as the Notch downstream target Hes1 were downre-
gulated in the mutant pituitary glands, detected by qRT-
PCR (Figure 3I). Therefore, in the absence of Notch
signaling after the onset of Prop1 expression in the RP,
the SOX2+ progenitor cells in the RP fail to maintain self-
renewal, leading to a reduced population of proliferative
progenitors and, consequently, a complete depletion of
pituitary stem cells in the postnatal pituitary gland.
As expected, the mutant mice were able to survive until
adulthood. They were smaller than their age-matched
wild-type controls by body weight (Figures S3A and S3B),
and the pituitary glands of mutant animals were hypoplas-
tic. Immunofluorescence staining revealed that all cell
types in the anterior lobe were present but with a reduced
number (Figures 3J–3Q). The intermediate lobe, labeled
by POMC staining, which encloses the posterior lobe and
separates the posterior lobe from the anterior lobe in
wild-type glands, expanded laterally in the mutants,
whereas the medial regions of the gland lacked intermedi-
ate lobe cells and, as a result, allowed direct contact be-
tween the anterior and posterior lobes (Figures 3P and
3Q). Moreover, to further verify that SOX2+ stem cells
were absent in mutant glands, in vitro pituitary cultures1200 Stem Cell Reports j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 Thwere established. Pituitary spheres, labeled by SOX2 stain-
ing, were readily detectable in wild-type culture, whereas
there were barely any in the mutant culture (Figures 3R–
3T). Collectively, these data demonstrate that Notch
signaling is essential for the proliferation andmaintenance
of postnatal pituitary stem cells as well as the size and
morphology of the pituitary gland.
To examine whether Notch signaling is required cell-
autonomously in SOX2+ cells for their maintenance, we
generated Rbp-Jf/f, Sox2-CreERT2 mice. Tamoxifen was in-
jected for two consecutive days, and pituitary glands were
characterized 21 days later. There was a clearly decrease in
the number of SOX2+ cells in the mutant, particularly in
the very lateral periluminal region (Figures S3C–S3E). How-
ever, large numbers of SOX2+ cells still remained in the per-
iluminal region as well as in the anterior lobe, probably
because Sox2-CreERT2 cannot effectively label all SOX2+
cells after tamoxifen induction (Rizzoti et al., 2013; unpub-
lished data). Additionally, chemical inhibition of Notch
signaling by N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT) in the pituitary sphere
culture resulted in a significant reduction in the number
of pituitary spheres (Figure S3F). Therefore, Notch activa-
tion in SOX2+ cells is necessary for their proliferation and
maintenance.
Prop1 Functions Downstream of Sox2
It has been shown previously that expression of Prop1 in RP
is directly regulated by Notch signaling (Nantie et al., 2014;
Zhu et al., 2006). Here we demonstrated that Notch
signaling is required for maintaining SOX2+ cells in the
postnatal gland and that expression of PROP1 in SOX2+
stem cells is absent when Notch signaling is ablated (Fig-
ures 3C and 3D), suggesting that PROP1 may function
downstream of SOX2. Consistent with this notion, it has
been reported that Prop1 is downregulated in pituitary-spe-
cific Sox2 conditional knockout embryos (Jayakody et al.,
2012). To understand whether PROP1 might reciprocally
regulate SOX2 expression, we examined SOX2+ cells in
Prop1/ mice. Immunofluorescence of SOX2 at P10 re-
vealed that SOX2+ stem cells still persist in the periluminal
region, as well as in the anterior lobe, in the absence of
Prop1 (Figures S3G and S3H). Together, these results suggest
that SOX2 functions upstream of PROP1.
Functions of SOX2+ Stem Cells and Notch Signaling in
the Postnatal Expansion of the Pituitary Gland
Through deletion of Rbp-J using Prop1-Cre, we generated
animals that survive after birth but lack SOX2+ stem cells
and are defective inNotch activation in the pituitary gland.
This provided us with an animal model in which to inves-
tigate the roles of SOX2+ cells and Notch signaling in post-
natal pituitary gland function and homeostasis.e Authors
Figure 3. SOX2+ E-Cadherin+ Pituitary Stem Cells Are Depleted Gradually in Hypoplastic and Dysmorphic Pituitary Glands in
Postnatal Rbp-Jf/f, Prop1-Cre Mutants
(A–H) Double immunofluorescence labeling of SOX2/E-Cadherin (A, B, E, and F; magnification, 2003), SOX2/PROP1 (C and D; magnifi-
cation, 4003), and SOX9/E-Cadherin (G and H; magnification, 2003) at P0 (A and B), P3 (C and D), and P10 (E–H) in wild-type controls
(A, C, E, and G) and Rbp-Jf/f, Prop1-Cre mutants (B, D, F, and H).
(I) qRT-PCR of a 3-month-old wild-type control and Rbp-Jf/f, Prop1-Cremutant pituitary revealed reduced expression of Rbp-J, Hes1, Hey1,
Prop1, Sox2, and E-Cadherin. Data are represented as mean ± SEM (n = 3 mice). *p < 0.05, **p < 0.01. CKO/C, conditional knockout/control.
(J–Q) Immunofluorescence labeling of GH/FSHb (J and K), LHb/TSHb, and POMC/PRL (N–Q) in 1-month-old wild-type controls (J, L,
N, and P) and Rbp-Jf/f, Prop1-Cremutants (K, M, O, and Q) showed that all cell types are present in the mutant glands. Lower magnification
(253) of the gland (P and Q) revealed that, in the Rbp-Jf/f, Prop1-Cre mutants, the intermediate lobe is expanded laterally and dis-
continued in the ventral medial region, leading to a direct interaction of the anterior lobe with the posterior lobe (arrowhead).
(R–T) Immunofluorescence labeling of SOX2 (R and S) and quantification (T) of pituitary spheres cultured from a 3-month-old wild-type
control (CTL) and Rbp-Jf/f, Prop1-Cre mutant. Data are represented as mean ± SEM (n = 3 mice). *p < 0.05, **p < 0.01.
Scale bars, 100 mm (A, B, and E–H), 50 mm (C and D), 200 mm (J and O), 500 mm (P and Q), and 75 mm (R and S).
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Figure 4. Both SOX2+ Stem Cells and
PIT1+ Cells Exhibit Reduced Proliferation
in the Anterior Lobe of Rbp-Jf/f, Prop1-
Cre Mutants at P1
(A–D) Double immunofluorescence labeling
of SOX2/KI67 (A and B) and PIT1/KI67
(C and D) in wild-type control (A and C) and
Rbp-Jf/f, Prop1-Cre mutants (B and D) at P1.
(E) Quantification of KI67+ proliferating
cells in the anterior lobe in the control and
mutant (CKO) at P1. Data are represented as
mean ± SEM (n = 3 mice, *p < 0.05).
(F) Quantification of SOX2+ and PIT1+ cells
among KI67+ proliferating cells in the con-
trol and mutant. Data are represented as
mean ± SEM (n = 3 mice, **p < 0.01).
(G) Quantification of SOX2+ KI67+ cells
among SOX2+ cells. Data are represented as
mean ± SEM (n = 3 mice, *p < 0.05).
(H) Quantification of PIT1+ KI67+ cells
among PIT1+ cells. Data are represented as
mean ± SEM (n = 3 mice, **p < 0.01).
Scale bars, 100 mm.Because pituitary glands undergo expansion after birth,
we first examined whether postnatal pituitary stem cells
are required for this initial postnatal growth. At P1 in the
wild-type pituitary gland, both periluminal stem cells and
stem cell clusters in the anterior lobe continued to prolifer-
ate, and they represented approximately 64% of all KI67+
proliferating cells in the anterior lobe (Figures 4A and 4F).
Meanwhile, after an initial cell-cycle arrest accompanying
lineage commitment and terminal differentiation during
embryonic development, PIT1+ cells resumed prolifera-
tion, and they represented approximately 12% of all
KI67+ cells in the anterior lobe (Figures 4C and 4F). By
contrast, in the mutant glands, where most of the SOX2+
stem cells were absent, the total number of KI67+ prolifer-
ating cells was reduced significantly to 51% of the controls
(Figure 4E), of which about 16% represented the remaining
SOX2+ cells (Figure 4F). Furthermore, the proportion of
SOX2+ cells that were proliferating (SOX2+KI67+/SOX2+)1202 Stem Cell Reports j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 Thwas also decreased greatly (Figure 4G), consistent with
the idea that the remaining SOX2+ stem cells failed to
maintain self-renewal in the absence of Notch signaling.
Interestingly, the proportion of PIT1+ cells that were prolif-
erating (PIT1+KI67+/PIT1+) in the mutants was also
decreased significantly (Figure 4H), suggesting a delay of
PIT1+ cells in their re-entry into the cell cycle in the mu-
tants. Taken together, these data suggest that SOX2+ stem
cells make a significant contribution to neonatal pituitary
expansion and that SOX2+ stem cells and Notch signaling
are also required to ensure proper timing of re-entry of
PIT1+ cells into the cell cycle.
However, despite a progressively diminished postnatal
stem cell population and decreased cell proliferation at
P1, the mutant pituitary glands continued to proliferate
and expand postnatally. At P10, the labeling index in the
anterior lobe of the mutant gland is similar to that of the
wild-type control, in contrast to P1, when a significante Authors
Figure 5. Proliferation of SOX2+ Cells Is Diminished Gradually, and PIT1+ Cells Make up the Majority of Proliferating Cells in the
Postnatal Pituitary Gland
(A–F) Double immunofluorescence labeling of CldU/IdU (A and B) , PIT1/IdU (C and D), and SOX2/IdU (E and F) in the wild-type control
(A, C, and E) and Rbp-Jf/f, Prop1-Cre mutants (B, D, and F) at P10.
(G) Quantification of PIT1+ or SOX2+ cells among dividing cells at P10. Data are represented as mean ± SEM (n = 3 mice, **p < 0.01).
(H–M) Double immunofluorescence labeling of CldU/IdU (H and I) , PIT1/IdU (J and K), and SOX2/IdU (L and M) in the wild-type control
(H, J, and L) and Rbp-Jf/f, Prop1-Cre mutants (I, K, and M) at P20.
(N) Quantification of PIT1+ or SOX2+ cells among dividing cells at P20. Data are represented as mean ± SEM (n = 3 mice).
(O) Labeling index of the wild-type pituitary glands at different postnatal stages. Data are represented as mean ± SEM (n = 3 mice).
(P) Respective quantification of PIT1+ and SOX2+ cells among IdU+ dividing cells in the anterior lobe of wild-type pituitaries at different
postnatal stages. Data are represented as mean ± SEM (n = 3 mice).
Scale bars, 100 mm.difference was observed (Figure S4). To further examine the
proliferation dynamics, we performed a double-thymidine
analog incorporation assay by administering 5-chloro-20-
deoxyuridine (CldU) and 5-Iodo-20-deoxyuridine (IdU) on
consecutive days. CldU/IdU double labeling starting at
P10 revealed that, in wild-type animals, dividing cells
were present in all three lobes of the pituitary gland (Fig-
ures 5A–5F; and data not shown). At this stage, 63% of
the dividing cells in the anterior lobe were PIT1+ cells
(PIT1+ IdU+/IdU+), and a relatively smaller proportion of
dividing cells (19%) were SOX2+ stem cells. Similarly, inStem Cell Repthe mutants, PIT1+ cells continued to proliferate in the
absence of postnatal SOX2+ stem cells and represented
the majority of dividing cells (72%) (Figure 5G). Therefore,
expansion of the postnatal gland at this stage was largely
contributed to by proliferation of existing, committed cells
rather than pituitary SOX2+ stem cells. Furthermore, dou-
ble labeling of CldU and IdU revealed that therewere barely
any detectable CldU+ IdU+ cells in either the anterior lobe
or in the periluminal region (Figures 5A and 5B), suggesting
that, in contrast to the intestine or other organs with fast
cell turnover, there were no transiently amplifyingorts j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 The Authors 1203
progenitor cells that may contribute to the postnatal
expansion of the pituitary gland at this stage. Instead,
dividing cells in the pituitary gland appear to enter a resting
period and do not immediately reenter the cell cycle.
Similar CldU/IdU labeling performed at P20 showed that
postnatal SOX2+ stem cells were mostly quiescent and
not dividing actively at this stage, whereas PIT1+ cells
made up about 87% of the dividing cells in the anterior
lobe in both the wild-type andmutants, and no transiently
amplifying progenitor cells were detected (Figures 5H–5N).
To further characterize cell divisions in postnatal pituitary
gland expansion, single IdU labeling at different postnatal
time points was performed in wild-type animals. Immuno-
fluorescence assays and further analyses revealed that the
overall labeling index in the anterior lobe peaked at P3
and then decreased gradually (Figure 5O). Quantifications
of dividing cells among SOX2+ and PIT1+ cells, respectively,
revealed that the actively dividing SOX2+ stem cells
declined significantly, transitioning from a highly prolifera-
tive state in the neonatal stages to near quiescence a few
weeks after birth, whereas PIT1+ cells exhibited a temporally
delayed wave of proliferation and becamemostly quiescent
as well (Figures S5A and S5B). In the process of postnatal
expansion, PIT1+ cells gradually increased in cell number
and, ultimately, represented large proportions of dividing
cells in the mature pituitary gland (Figure 5P; Figure S5C).
To examine the contribution of SOX2+ cells in the post-
natal pituitary gland, we carried out lineage tracing exper-
iments using Sox2-CreERT2, ROSA26-EYFP mice (Arnold
et al., 2011). Tamoxifen was injected for two consecutive
days at P1 and P2, and animals were analyzed at P15.
Consistent with observations from others (Andoniadou
et al., 2013; Rizzoti et al., 2013), we observed that the
majority of YFP+ cells remained as SOX2+ stem cells and
that only a small percentage of YFP+ stem cells eventually
differentiated into distinct pituitary endocrine cells (Fig-
ure S5D; unpublished data).
In conclusion, these results, collectively, suggest that
SOX2+ stem cells are critical for neonatal pituitary expan-
sion by self-renewal, differentiating into distinct pituitary
cell lineages, and that Notch signaling is essential for post-
natal expansion largely by maintaining SOX2+ cells and
regulating the proper timing of PIT1+ cell re-entry into
the cell cycle.
Roles of Pituitary Postnatal Stem Cells in Pituitary
Plasticity
An interesting feature of the pituitary gland is its plasticity.
The composition and cell content of the gland changes to
meet the physiological demands. One example is that the
number of lactotropes in the rat pituitary gland increases
3-fold during pregnancy and lactation (Levy, 2002). It is
generally believed that transdifferentiation and increased1204 Stem Cell Reports j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 Thlactotrope proliferation account for this change, although,
in the mouse, no lactotroph transdifferentiation has been
observed during pregnancy and lactation (Castrique et al.,
2010). However, it is not known whether pituitary stem
cells play a role in these processes. We therefore probed
the possibility of whether pituitary stem cells, although
mostly quiescent during their adult life, might reenter the
cell cycle and function in these processes. We examined
cell proliferation in the pituitary glands of wild-type preg-
nant females on days 13 and 18 of pregnancy and day 7 of
lactation aswell as in age-matched virgin females (Figure 6).
Overall, cell proliferation in the pituitary gland increased
toward the end of pregnancy at E18.5 and while lactating
at P7. Double labeling of SOX2/KI67 and PIT1/KI67 re-
vealed that SOX2+ stem cells did not undergo enhanced
proliferation under these conditions. In contrast, PIT1+
cells were still the major proliferating cells in the anterior
lobe. Among them, only a very small number of PRL+
KI67+ cells could be identified (Figure 6). Similar prolifera-
tion dynamics were observed in mutant pituitary glands
(Figure S6). These data suggest that SOX2+ stemcells remain
mostly quiescent in these processes and are unlikely to play
a significant role during pregnancy and lactation. This is
consistent with our observation that the number and size
of litters generated from mutant females were not signifi-
cantly different from those of control wild-type females,
and the mutant females did not exhibit any detectable de-
fects in lactation (8.4 ± 0.9/litter for wild-type and 7.7 ±
0.9/litter for mutant animals, mean ± SEM, n = 3 litters,
p = 0.12; data not shown). Therefore, we conclude that
Notch signaling and Notch-dependent SOX2+ stem cells
are not absolutely required for pituitary functions in the
process of pregnancy and lactation.
A second example of pituitary plasticity is characterized
by the fact that there are increases in the number of prolif-
erating cells and in the number of corticotropes in
response to bilateral adrenalectomy (ADX) because of
disruption of the negative feedback imposed by glucocorti-
coid from the target organ, the adrenal gland (Levy, 2002;
Nolan and Levy, 2006). qRT-PCR from wild-type pituitary
glands after ADX showed increases in the RNA levels of
Pomc and the proliferating marker Ki67 (Figure 7A). Inter-
estingly, RNA levels of glucocorticoid receptor (GR)
declined gradually, compatible with the idea that there is
a disruption of negative feedback upon ADX. We ques-
tioned whether postnatal pituitary stem cells make up
those proliferating cells after ADX in the pituitary gland.
We performed surgery in wild-type animals. Double immu-
nofluorescence labeling of SOX2/CldU in wild-type ani-
mals revealed that SOX2+ cells contributed to 2.2% of cells
labeled with CldU in sham surgery, and the respective
contribution changed to 6.9% upon ADX (Figures 7B–
7F). These data suggest that SOX2+ stem cells could bee Authors
Figure 6. Characterization of Proliferating Cells in 3-Month-Old Wild-Type Control Mice during Pregnancy and Lactation
(A–L) Double immunofluorescence labeling of SOX2/KI67 (A–D), PIT1/KI67 (E–H), and PRL/KI67 (I–L) at different stages of pregnancy
and lactation. Scale bars, 100 mm.reactivated to proliferate by ADX. However, SOX2+ stem
cells were not the only cell types that were stimulated to
proliferate upon ADX. PIT1+ cells as well as ACTH+ cortico-
tropes also exhibited increased proliferation, with PIT1+
cells representing the majority of proliferating cells and
ACTH+ corticotropes representing a much lower propor-
tion than SOX2+ cells (Figures 7D, 7E, 7G, and 7H; data
not shown). Consistently, GR expression was detected in
PIT1+ cells (Figure S7). These results suggest that ADX-
induced cell proliferation in the pituitary gland is not
cell type specific. We also performed similar experiments
in both control littermates and the mutant mice. ADX
induced an 3-fold increase in the number of cells incor-
porating CldU in the anterior lobe of wild-type pituitary
glands. We did not detect a significant deficit in the re-
sponses to ADX in the mutant animals with respect to
both the increase in the number of proliferating cells and
the increase of ACTH+ cells (Figures 7G–7K). These results
reveal that ADX can elicit general reactivation of multiple
cell types in the pituitary gland and that SOX2+ stem cells
make a limited contribution to the overall responses in the
pituitary gland.
DISCUSSION
Adult stem cells have been identified in the postnatal pitu-
itary gland. These are groups of heterogeneous cells ex-Stem Cell Reppressing SOX2, SOX9, LHX3, PROP1, E-Cadherin, and
NES located either in the marginal zone between the inter-
mediate and anterior lobes or scattered in the anterior lobe
(Chen et al., 2009; Fauquier et al., 2008; Garcia-Lavandeira
et al., 2009; Gleiberman et al., 2008; Rizzoti, 2010; Vanke-
lecom and Chen, 2014). It has been suggested previously
that mouse pituitary adult stem cells are uniquely set aside
during embryonic pituitary development and only
contribute prominently to postnatal pituitary growth
(Gleiberman et al., 2008). In this study, we showed that
these stem cells were labeled by the LacZ or GFP reporters
in the lineage-tracing experiment using the RP-specific
Prop1-Cre line, suggesting that pituitary stem cells are
derived from the embryonic RP progenitors and that they
continue to proliferate and differentiate to contribute to
postnatal pituitary expansion. One common feature of
RP progenitors and postnatal stem cells is their expression
of the transcription factor SOX2, which has been deter-
mined to be expressed in many adult stem cells (Andonia-
dou et al., 2013; Arnold et al., 2011; Rizzoti et al., 2013).
In this study, we demonstrate that postnatal pituitary
SOX2+ stem cells are maintained by the canonical Notch
signaling pathway. Our result is consistent with the finding
that Notch signaling is essential for the long-term mainte-
nance of neural stem cells in the adult brain hippocampus,
where it has been shown that RBP-J is recruited to the Sox2
promoter and activates its expression (Ehm et al., 2010). Inorts j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 The Authors 1205
Figure 7. SOX2+ Cells Are Mobilized upon
Target Organ Ablation but Contribute a
Small Percentage of Overall Pituitary
Gland Activation
(A) qRT-PCR of Pomc, Ki67, and glucocorti-
coid receptor (GR) in the pituitary glands
after bilateral ADX in wild-type control
mice. Data are represented as mean ± SEM
(n = 3 mice, *p < 0.05, **p < 0.01).
(B–E) Double immunofluorescence labeling
of SOX2/CldU (B and C) and PIT1/CldU
(D and E) in sham- (B and D) and ADX-
operated (C and E) wild-type pituitary
glands. The arrows indicate co-labeling.
(F) Quantification of SOX2+ cells among
mitotic cells in sham- and ADX-operated
wild-type pituitary glands. Data are repre-
sented as mean ± SEM (n = 3 mice, *p <
0.05).
(G–J) Double immunofluorescence labeling
of POMC/CldU in sham- (G) and ADX-oper-
ated (H) control animals and Rbp-Jf/f,
Prop1-Cre mutants (CKO, I and J).
(K) Quantification of relative changes in
mitotic cells in response to ADX in wild-type
control and Rbp-Jf/f, Prop1-Cre mutants.
Data are represented as mean ± SEM (n = 3
mice).
Scale bars, 100 mm (B–E) and 200 mm (G–J).the absence of Notch signaling, the pituitary stem cells
were depleted gradually in the postnatal pituitary gland.
This was accomplished by employing Prop1-Cre, which is
expressed in all RP progenitors, but not so early to interfere
with the lineage commitment program, in which Notch
signaling plays a pivotal role (Zhu et al., 2006). In addition,
there was a reduction in the number of SOX2+ cells in
mutant mice in which Rbp-J was specifically deleted in
SOX2+ cells. Consistent with these data, chemical inhibi-
tion of Notch activation in primary culture resulted in a1206 Stem Cell Reports j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 Thdecreased number of pituitary spheres. Taken together,
these results reveal that Notch signaling controls the fate
choices of RP progenitors in a narrow developmental win-
dow, whereas it is required continuously for the mainte-
nance of SOX2+ pituitary stem cells.
During embryonic pituitary organogenesis, SOX2+ cells
exhibit a remarkable capacity for proliferation (Figure S1L;
Davis et al., 2011), whereas, after birth, these cells remain
mitotically active for the initial 3 weeks and then become
mostly quiescent after this period. For the first 3 days aftere Authors
birth, they are the dominant cell type undergoing cell divi-
sion, and their postnatal proliferation makes a significant
contribution to pituitary gland expansion. We show that
postnatal pituitary expansion can be attributed to succes-
sive and overlapping waves of proliferation of SOX2+
stem cells and committed/differentiated cells, as exempli-
fied by PIT1+ cells. How the mitotic properties of SOX2+
stem cells are regulated dynamically during embryonic
development, postnatal growth, and subsequent homeo-
stasis remains to be fully elucidated.
In the absence of SOX2+ stem cells and Notch signaling
in Rbp-Jf/f, Prop1-Cre mutant mice, the pituitary glands are
hypoplastic and dysmorphic. Interestingly, re-entry of
PIT1+ lineages into the cell cycle after birth is delayed in
themutant. Consistentwith our finding, reduced postnatal
pituitary proliferation has been observed in Notch2f/f,
Foxg1-Cre mice with limited loss of SOX2+ stem cells and
partial loss of Notch signaling (Nantie et al., 2014). We
have shown previously that ablating Notch signaling in
PIT1+ cells by expressing a dominant-negative form of
RBP-J did not result in any detectable phenotype, suggest-
ing that Notch signaling is not required in lineage-
committed cells (Zhu et al., 2006). Taken together, these
results imply an additional role of Notch signaling during
late pituitary development in regulating cell maturation
and setting up the gland for postnatal expansion. Interest-
ingly, it has been demonstrated recently that ectopic
expression of the activated form of b-catenin in SOX2+
stem cells gives rise to pituitary tumors in a non-cell-auton-
omous manner (Andoniadou et al., 2013), consistent with
the idea that SOX2+ cells can function as a signaling center
under specific conditions to have a profound effect in the
pituitary gland. It is tempting to speculate that SOX2+
stem cells may additionally contribute to postnatal pitui-
tary expansion by providing a paracrine signal for regu-
lating the proper timing of PIT1+ cell re-entry into the
cell cycle.
Tissue homeostasis in the adult stage is maintained by
different mechanisms. In fast turnover tissues, e.g., the in-
testine and epidermis, tissue maintenance is coordinated
by tissue-specific stem cells through self-renewal and differ-
entiation processes, whereas initial analysis in slow turn-
over tissue, e.g., the pancreas, tissue homeostasis can be
largelymediated by replication of differentiated cells (Bren-
nand and Melton, 2009; Simons and Clevers, 2011). Our
data reveal that SOX2+ stem cells and PIT1+ differentiated
cells become essentially quiescent a few weeks after birth
and that they divide slowly in the adult pituitary gland.
Our findings suggest that, after an initial postnatal expan-
sion period, the adult pituitary gland is maintained by
stochastic cellular self-replication rather than stem cell
replenishment. Consistent with this notion, genetic line-
age tracing of SOX2+ cells in the young adult pituitaryStem Cell Repgland has shown that SOX2+ labeled cells rarely differen-
tiate into different pituitary lineages and mostly remain
as SOX2+ stem cells (Andoniadou et al., 2013; Rizzoti
et al., 2013). In addition, we showed that, during preg-
nancy and lactation, SOX2+ cells are not mobilized readily
and not essential for these processes. However, we found
that SOX2+ cell can be re-activated following bilateral adre-
nalectomy when the negative feedback inhibition is elimi-
nated, although they represent only a minor proportion of
cells that were mobilized for proliferation, consistent with
recent findings (Langlais et al., 2013; Rizzoti et al., 2013).
Indeed, ADX responses were not affected significantly in
the absence of SOX2+ cells, suggesting that, although
SOX2+ cells can be mobilized and make a limited contribu-
tion to corticotrope expansion (Rizzoti et al., 2013), they
are not an essential component for the functions of a
mature gland under the conditions we examined. Interest-
ingly, we observed that PIT1+ cells are alsomobilized to pro-
liferate under pregnancy/lactation, target organ ablation,
and partial hypophysectomy (unpublished data) and that
they constitute a rather large proportion of proliferating
cells. These findings raise the intriguing possibility that
PIT1+ cells, and potentially other cell types, may function
as reserve cells and contribute to pituitary plasticity in
response to physiological demands. Indeed, it has been
demonstrated recently that differentiated cells of the stom-
ach and lung can function as stem cells and give rise to
various cell types of the tissues, revealing enormous plas-
ticity of cells (Stange et al., 2013; Tata et al., 2013).Whether
and how PIT1+ cells and other cells in the pituitary gland
respond to physiological demands andwhether transdiffer-
entiation is involved are interesting questions to be
investigated.EXPERIMENTAL PROCEDURES
Mice
Prop1-Cre transgenic mice were generated by using the 2.2-kb pro-
moter and enhancer region of the Prop1 gene to drive CRE recom-
binase expression. Rbp-Jf/f mice were provided by Dr. T. Honjo
(Tanigaki et al., 2002). Sox2-CreERT2 (Arnold et al., 2011), Rosa26-
LacZ reporter Gt(ROSA)26Sortm1Sor (Soriano, 1999), Z/EG
(Tg(CAG-Bgeo/GFP) (Novak et al., 2000), and Rosa26-EYFP (Srini-
vas et al., 2001) mice were obtained from Jackson Laboratory.
Noon of the day of the vaginal plug was considered E0.5. For line-
age-tracing experiments, tamoxifen was injected at P1 and P2 at
0.075 mg/g. Care and experimentation were carried out in accor-
dance with the Institutional Animal Care and Use Committee of
University of California at San Diego.
CldU/IdU Labeling
For CldU and IdU labeling, the animals received one intraperito-
neal injection of CldU for 1 day at noon, followed by a similar in-
jection of IdU for 1 day (at 100 mg/g body weight), and wereorts j Vol. 5 j 1196–1209 j December 8, 2015 j ª2015 The Authors 1207
sacrificed 1 day after the last injection. For the postnatal labeling
index experiment, the animals were injected with IdU at
noon and sacrificed 2 hr later. CldU and IdU were obtained from
Sigma.Cell Counting and Statistical Analysis
At least 2,000 DAPI+ cells from the anterior lobe and periluminal
region from at least four comparable fields of different sections
were counted manually per sample. Results are presented as
mean ± SEM. Two-tailed Student’s t test was used to compare the
difference between two sets of values. p % 0.05 was considered
to indicate statistical significance (*p% 0.05, **p% 0.01).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and one table and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2015.
11.001.
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